, , , ,

Trastunix (Trastuzumab) 440mg

0.00$

+ Free Shipping

Trastunix 440mg contains Trastuzumab, a targeted monoclonal antibody used to treat certain HER2-positive cancers. It is commonly prescribed for HER2-positive breast cancer and HER2-positive metastatic gastric or gastroesophageal junction cancer. Trastuzumab works by targeting HER2 receptors on cancer cells, slowing their growth, and helping the immune system destroy abnormal cells.

Field Details
Original Brand Herceptin
Generic Brand Trastunix 440
Generic Name Trastuzumab 440mg
Pack Size 1 Vial
Use / Indications HER2-Positive Breast Cancer, HER2-Positive Gastric Cancer
Manufacturer —
Status Prescription Only Medicine
Guaranteed Safe Checkout

Introduction to Herceptin (Trastuzumab) 440mg

Herceptin (Trastuzumab) 440mg is a targeted prescription medicine used in the treatment of certain HER2-positive cancers, especially breast cancer and gastric cancer. This medicine belongs to a specialized group of oncology drugs that work by targeting specific cancer cell receptors and helping slow or stop tumor growth.

Herceptin (Trastuzumab) 440mg is classified under Prescription Medicines, Oncology Medicines, Targeted Cancer Therapies, and Monoclonal Antibodies. It contains Trastuzumab, which works by binding to the HER2 receptor and interfering with cancer cell growth and survival.

In some markets, Trastunix 440mg is available as a local brand containing the same active ingredient Trastuzumab, offering a similar therapeutic effect when prescribed by a qualified healthcare professional.

What Is Herceptin (Trastuzumab) 440mg?

Herceptin is the original brand name for Trastuzumab, an injectable medication widely used for the treatment of several HER2-positive cancers.

Trastuzumab belongs to a class of medicines known as Monoclonal Antibodies. These medicines are designed to recognize and attach to specific proteins on cancer cells.

Generic or local brands such as Trastunix 440mg contain the same active compound and may be used depending on physician recommendation and regional availability.

Drug Class and Mechanism of Action

Trastuzumab is classified as a monoclonal antibody and targeted antineoplastic agent with strong anti-HER2 activity.

How Trastuzumab Works

It works in several ways:

  • Binds specifically to HER2 receptors on cancer cells
  • Blocks cancer cell signaling that promotes growth and division
  • Activates immune responses that help destroy abnormal cells

Through these mechanisms, Trastuzumab helps slow or stop the progression of certain HER2-positive cancers.

How Herceptin Works in the Body

Some cancer cells produce too much HER2 protein, which can cause them to grow more aggressively. Herceptin helps target these cells by attaching to the HER2 receptor and disrupting tumor-promoting signals.

Key Actions of Trastuzumab

  • Targeting HER2-positive cancer cells directly
  • Slowing cell growth and replication
  • Supporting immune-mediated destruction of cancer cells

Some local brands such as Trastunix deliver the same active compound, allowing similar HER2-targeted cancer treatment when prescribed appropriately.

Medical Uses of Herceptin (Trastuzumab) 440mg

Herceptin 440mg is widely prescribed for several serious HER2-positive cancers.

Herceptin for Breast Cancer

For patients with HER2-positive breast cancer, Herceptin is commonly used alone or together with chemotherapy and other cancer treatments.

Potential Benefits

  • Reduced risk of cancer recurrence
  • Improved disease-free and overall survival
  • Better control of HER2-positive tumor growth

Local brands like Trastunix 440mg may also be used under medical supervision when Trastuzumab therapy is recommended.

Herceptin for Gastric Cancer

Herceptin is also used in HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma, usually in combination with chemotherapy.

Treatment Benefits

  • Improved treatment response in HER2-positive disease
  • Better control of advanced tumor progression
  • Support for targeted treatment in selected patients

Who Can Take Trastunix 440mg?

Because Trastuzumab is a potent medicine, treatment should always be supervised by an experienced healthcare provider.

Eligibility Criteria

Patients may be prescribed Herceptin if they:

  • Have HER2-positive breast cancer or gastric cancer confirmed by appropriate testing
  • Are considered suitable for intravenous targeted therapy
  • Can undergo regular monitoring during treatment

Certain local brands such as Trastunix may also be considered depending on availability and physician decision.

Who Should Avoid Herceptin (Trastuzumab) 440mg

Herceptin should NOT be used by:

  • Individuals with known hypersensitivity to Trastuzumab or any of its components
  • Patients with severe uncontrolled infections unless advised by a specialist
  • Patients with significant heart problems without careful medical evaluation

Herceptin (Trastuzumab) 440mg Dosage and Administration

Standard Dosage Guidelines

Typical dosage recommendations include:

  • Herceptin 440mg administered by intravenous infusion
  • Dosing schedule depends on body weight, treatment protocol, and indication
  • Should be given by trained healthcare professionals in a clinical setting
  • Dose may be used as a loading dose followed by maintenance doses

Dosage Adjustments

Doctors may adjust treatment depending on:

  • Cardiac function monitoring results
  • Infusion-related reactions
  • Overall treatment response and tolerability

Side Effects of Herceptin 440mg

Like all cancer medicines, Herceptin may cause side effects.

Common Side Effects

  • Fever and chills
  • Nausea or diarrhea
  • Fatigue and weakness
  • Headache or mild infusion reactions

Serious Side Effects

  • Heart Problems: Reduced heart function or congestive heart failure
  • Infusion Reactions: Breathing difficulty, severe fever, or low blood pressure
  • Lung Complications: Serious pulmonary reactions in rare cases

Patients should report any unusual symptoms to their doctor immediately.

Storage:
Store below 25°C in a cool, dry place, protected from direct sunlight. Keep the vial in its original packaging and out of reach of children. Follow manufacturer instructions for storage after reconstitution.

Frequently Asked Questions (FAQs)

1. Is Herceptin (Trastuzumab) 440mg chemotherapy?

No. Herceptin is not traditional chemotherapy. It is a targeted monoclonal antibody therapy designed to act specifically on HER2-positive cancer cells.

2. How is Herceptin 440mg given?

It is usually administered by intravenous infusion in a hospital or oncology clinic under medical supervision.

3. Why is heart monitoring needed during Trastuzumab treatment?

Trastuzumab may affect heart function in some patients, so doctors often recommend regular cardiac assessment during therapy.

4. Can Trastunix 440mg be used for all breast cancer patients?

No. It is used only in patients whose cancer is confirmed to be HER2-positive through appropriate diagnostic testing.

5. Can pregnant women take Trastunix 440mg?

Trastunix 440mg should generally be avoided during pregnancy unless clearly advised by a specialist, as it may harm the fetus.

6. Is Trastunix 440mg the same as Herceptin?

Trastunix 440mg contains Trastuzumab, the same active ingredient found in Herceptin. Local or biosimilar versions may be available depending on market authorization and physician recommendation.

7. Do I need a prescription to buy Trastunix (Trastuzumab) 440mg?

Yes. Trastunix 440mg is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.

Medical Disclaimer

Disclaimer:
The information provided on this page is for educational and informational purposes only and should not be considered medical advice. Herceptin (Trastuzumab) is a prescription-only medication and must be used strictly under the supervision of a qualified healthcare professional. Always consult your physician before starting, stopping, or changing any medication.

Let's chat